COVID-19 Bulletin: 23 August 2021 (E)
"First Nasal Vaccine Developed by Bharat Biotech supported by DBT-BIRAC gets nod of regulator for Phase 2 Trial,Indian Immunologicals receive manufacturing license under Department of Biotechnology - Mission Covid Suraksha Project for Augmentation of Manufacturing Capacity for COVAXIN,Covid vaccine for children may be available by September in India.All these are wrapped in this week's COVID-19 Bulletin "
